More on ALMS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.1 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Alumis (NQ:ALMS)
Delayed: 9.49 -12.32 (56.49%)
Prev. Close $21.81  
Open$9.93 
52 Wk High$ 
52 Wk Low$ 
Day High$11.06 
Day Low$8.75 
P/E N/A  
EPS$ 
Volume21,615,414 

Friends, Peers and Foes (?): BFRG CYCN (more...)

Sep 1, 2026 07:32 AM Alumis SLE trial fails primary endpoints; subgroup data guides Phase 3
Sep 1, 2026 07:26 AM Alumis (ALMS) Halted, News Pending
Aug 17, 2026 06:43 AM H.C. Wainwright Reiterates Neutral Rating on Alumis Inc (ALMS)
Aug 17, 2026 06:19 AM Form SCHEDULE 13D ALUMIS INC. Filed by: Foresite Capital Fund VI LP
Aug 13, 2026 04:20 PM Form 10-Q ALUMIS INC. For: Jun 30
Aug 13, 2026 04:09 PM Form 8-K ALUMIS INC. For: Aug 13
Aug 13, 2026 04:01 PM Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements
Aug 10, 2026 04:07 PM Form 8-K ALUMIS INC. For: Aug 10
Aug 10, 2026 04:06 PM Alumis reports 54% complete skin clearance in psoriasis drug trial
Aug 10, 2026 04:06 PM Envudeucitinib Long-term Data Positioned to Set a New Standard for Plaque Psoriasis Treatment, Delivering Highest Reported PASI 100 Skin Clearance Among Oral Therapies
View All Articles

Entities mentioned with ALMS

View All Entities